ResearcherShenyang Pharmaceutical UniversityNo recent work listed
Lixia Chen
Matched on ORCID iD 0000-0003-2196-1428; OpenAlex author ID A5100679476. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 5
- Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming. Last author DOI 10.1007/s00109-022-02181-8↗
- Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. Co-author DOI 10.1016/j.cbi.2019.108913↗
- Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH. Last author DOI 10.1039/c9fo00394k↗
- 8-Chrysoeriol, as a potential BCL-2 inhibitor triggers apoptosis of SW1990 pancreatic cancer cells. Co-author DOI 10.1016/j.bioorg.2018.01.042↗
- The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Co-author DOI 10.1039/c8fo00033f↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hua Li · 5 shared papers, 2018–2022 · strength 0.59
- Paper Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism r… DOI 10.1007/s00109-022-02181-8↗
- Paper Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. DOI 10.1016/j.cbi.2019.108913↗
- Paper The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. DOI 10.1039/c8fo00033f↗
- Mengzhu Zheng · 2 shared papers, 2019–2022 · strength 0.27
- Zhimei Li · 2 shared papers, 2018 · strength 0.20
- Yueying Yang · 1 shared paper, 2022 · strength 0.16
- Chao Zhao · 1 shared paper, 2020 · strength 0.13
- Yiwen Zhang · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.